The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2006
Filed:
Aug. 27, 2001
Catherine E. Burgess, Wethersfield, CT (US);
Pamela B. Conley, Palo Alto, CA (US);
William M. Grosse, Branford, CT (US);
Matthew Hart, San Francisco, CA (US);
Ramesh Kekuda, Stamford, CT (US);
Richard A. Shimkets, West Haven, CT (US);
Kimberly A. Spytek, New Haven, CT (US);
Edward Szekeres, Jr., Branford, CT (US);
James E. Tomlinson, Burlingame, CA (US);
James N. Topper, Los Altos, CA (US);
Ruey-bin Yang, San Mateo, CA (US);
Catherine E. Burgess, Wethersfield, CT (US);
Pamela B. Conley, Palo Alto, CA (US);
William M. Grosse, Branford, CT (US);
Matthew Hart, San Francisco, CA (US);
Ramesh Kekuda, Stamford, CT (US);
Richard A. Shimkets, West Haven, CT (US);
Kimberly A. Spytek, New Haven, CT (US);
Edward Szekeres, Jr., Branford, CT (US);
James E. Tomlinson, Burlingame, CA (US);
James N. Topper, Los Altos, CA (US);
Ruey-Bin Yang, San Mateo, CA (US);
Millennium Pharmaceuticals, Inc., Cambridge, MA (US);
Curagen Corporation, New Haven, CT (US);
Abstract
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.